Quantitative Two-Dimensional HRMAS 1H-NMR Spectroscopy-Based Metabolite Profiling of Human Cancer Cell Lines and Response to Chemotherapy

被引:48
作者
Bayet-Robert, Mathilde [1 ,2 ]
Loiseau, Dominique [3 ]
Rio, Pascale [4 ]
Demidem, Aicha [4 ]
Barthomeuf, Chantal [1 ]
Stepien, Georges [4 ]
Morvan, Daniel [1 ,2 ]
机构
[1] Univ Auvergne, Clermont Ferrand, France
[2] Ctr Lutte Canc Jean Perrin, Clermont Ferrand, France
[3] Univ Angers, INSERM, U694, Angers, France
[4] INRA, UMR 1019, F-63122 St Genes Champanelle, France
关键词
HRMAS; 2D H-1-TOCSY; quantification; metabolite profiling; human tumor cells; human fibroblasts; chemotherapy; MAGNETIC-RESONANCE-SPECTROSCOPY; CHOLINE PHOSPHOLIPID-METABOLISM; BREAST-CANCER; NMR-SPECTROSCOPY; TUMOR; DIFFERENTIATION; METABOLOMICS; METABONOMICS; PROGRESSION; FIBROBLASTS;
D O I
10.1002/mrm.22303
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
NMR spectroscopy-based metabolomics still needs development in quantification procedures. A method was designed for quantitative two-dimensional high resolution magic angle spinning (HRMAS) proton-NMR spectroscopy-based metabolite profiling of intact cells. It uses referencing of metabolite-related NMR signals to protein-related NMR signals and yields straightforward and automatable metabolite profiling. The method enables exploitation of only two-dimensionally visible metabolites and combination of one- and two-dimensional spectra, thus providing an appreciable number of screened metabolites. With this procedure, 32 intracellular metabolites were attributed and quantified in human normal fibroblasts and tumor cells. The phenotype of several tumor cell lines (MCF7, PC3, 143B, and HepG2) was characterized by high levels of glutathione in cell lines with the higher proliferation rate, high levels of creatine, low levels of free amino acids, increased levels of phospholipid derivatives (mostly phosphocholine), and lower lactate content in cell lines with the higher proliferation rate. Other metabolites such as fatty acids differed widely among tumor cell lines. The response of tumor cell lines to chemotherapy also was evaluated by differential metabolite profiling, bringing insights into drug cytotoxicity and tumor cell adaptive mechanisms. The method may prove widely applicable to tumor cell phenotyping. Magn Reson Med 63:1172-1183, 2010. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1172 / 1183
页数:12
相关论文
共 38 条
[1]   Glutamine, as a precursor of glutathione, and oxidative stress [J].
Amores-Sánchez, MI ;
Medina, MA .
MOLECULAR GENETICS AND METABOLISM, 1999, 67 (02) :100-105
[2]   Cellular responses to excess phospholipid [J].
Baburina, I ;
Jackowski, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9400-9408
[3]  
BAYETROBERT M, BREAST CANC IN PRESS
[4]   Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [J].
Beckonert, Olaf ;
Keun, Hector C. ;
Ebbels, Timothy M. D. ;
Bundy, Jacob G. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2007, 2 (11) :2692-2703
[5]   The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation [J].
Boren, J ;
Lee, WNP ;
Bassilian, S ;
Centelles, JJ ;
Lim, S ;
Ahmed, S ;
Boros, LG ;
Cascante, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28395-28402
[6]   Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR Spectroscopy [J].
Chen, JH ;
Enloe, BM ;
Weybright, P ;
Campbell, N ;
Dorfman, D ;
Fletcher, CD ;
Cory, DG ;
Singer, S .
MAGNETIC RESONANCE IN MEDICINE, 2002, 48 (04) :602-610
[7]   Pharmaco-metabonomic phenotyping and personalized drug treatment [J].
Clayton, TA ;
Lindon, JC ;
Cloarec, O ;
Antti, H ;
Charuel, C ;
Hanton, G ;
Provost, JP ;
Le Net, JL ;
Baker, D ;
Walley, RJ ;
Everett, JR ;
Nicholson, JK .
NATURE, 2006, 440 (7087) :1073-1077
[8]  
Delikatny EJ, 1996, INT J CANCER, V67, P72, DOI 10.1002/(SICI)1097-0215(19960703)67:1<72::AID-IJC13>3.0.CO
[9]  
2-E
[10]   Toward improved grading of malignancy in oligodendrogliomas using metabolomics [J].
Erb, G. ;
Elbayed, K. ;
Piotto, M. ;
Raya, J. ;
Neuville, A. ;
Mohr, M. ;
Maitrot, D. ;
Kehrli, P. ;
Namer, I. J. .
MAGNETIC RESONANCE IN MEDICINE, 2008, 59 (05) :959-965